4//SEC Filing
Johnson Wendy S. 4
Accession 0001209191-21-046254
CIK 0001637715other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 6:52 PM ET
Size
6.8 KB
Accession
0001209191-21-046254
Insider Transaction Report
Form 4
Johnson Wendy S.
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2021-07-08$1.97/sh+111,736$220,120→ 111,736 total - Exercise/Conversion
Stock option (right to buy)
2021-07-08−111,736→ 0 totalExercise: $1.97From: 2017-09-01Exp: 2028-04-04→ Common Stock (111,736 underlying)
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001652822
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 6:52 PM ET
- Size
- 6.8 KB